CONMED Corp — Director's Dealing 2025

May 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-05-29

Reporting Person: Farkas Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-29	Common Stock	M	1000	$55.70	Acquired	17346	Direct
2025-05-29	Common Stock	F	966	$57.69	Disposed	16380	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-29	SARs (Stock Appreciation Rights)	$55.70	M	1000	Disposed	2025-06-01	Common Stock (1000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.